Structure of the Herpes Simplex Virus Receptor

Status Completed

Clinical Trial Summary

This study will examine the structure of the receptor molecule for the herpes simplex virus (HSV) and determine if the receptor's structure is related to susceptibility to infection with the virus. There are two types of herpes virus-HSV-1 and HSV-2. HSV-1 commonly causes cold sores, and HSV-2 usually causes genital herpes. The herpes virus enters (infects) cells through protein molecules on the cell's surface. This study will explore possible differences between the structure of the HSV receptor molecule in different people to understand better how infection occurs. The study will also look at proteins on white blood cells (Fc receptors, cytokines and mannose binding protein) that may influence the risk of infection with HSV. Information from this study may lead to new treatments to prevent HSV infection.

People 18 years of age and older who are infected with HSV and people who are not infected with the virus may be eligible for this study. Participants will have blood drawn to confirm whether or not they have been infected with the virus. The blood sample will also be used to study the genes for the HSV receptor, Fc receptors, cytokines, mannose binding protein and related proteins on the white blood cells. No more than 40 milliliters (8 teaspoons) of blood will be drawn.

Participants who are found to have antibodies to HSV-2 will be offered counseling and advice on practicing safe sex techniques to help prevent sexually transmitted diseases, including HSV-2 infection.

Clinical Trial Description

Herpes simplex virus (HSV) causes genital, orolabial, or cutaneous lesions, keratitis, and encephalitis. Recently cellular receptors for HSV were isolated. The purpose of this study is to identify polymorphisms in the sequence of HSV receptor, cytokines or chemokines and to determine whether these polymorphisms correlate with susceptibility to infection by HSV or with symptoms of HSV. Blood samples from individuals who are seronegative, or seropositive (with or without symptoms of infection) for HSV-2 will be analyzed to determine the sequences of the HSV receptors, cytokines, chemokines, or related proteins. If a new genetic polymorphism is found, additional blood samples from individuals who are seropositive for HSV and from random blood donors will be analyzed to determine the frequency of the polymorphisms in seropositives and in the general population. Knowledge gained from this study should provide important insights into mechanisms of infection by HSV and may lead to novel therapies to block infection. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00001648
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Completed
Phase	N/A
Start date	August 20, 1997
Completion date	April 13, 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05468619` - Neonatal Phase 1 Valacyclovir Study	Phase 1
Withdrawn	`NCT02349828` - Antiviral Prophylaxis in a Burn Population	Phase 2/Phase 3
Recruiting	`NCT01176409` - Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?	Phase 3
Completed	`NCT04664127` - Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
Completed	`NCT00448227` - Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection	Phase 2
Completed	`NCT00000139` - Herpetic Eye Disease Study (HEDS) II	Phase 3
Completed	`NCT04239521` - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Completed	`NCT02209324` - Open-label Study of ASP2151 in Herpes Simplex Patients	Phase 3
Completed	`NCT00855309` - Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia	Phase 3
Completed	`NCT01602562` - Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients	Phase 3
Completed	`NCT00973466` - Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients	N/A
Completed	`NCT00698893` - Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults	Phase 1
Active, not recruiting	`NCT05298254` - A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes	Phase 1/Phase 2
Recruiting	`NCT03178747` - Tzanck Smear With Methylene Blue Stain for Herpes	Phase 3
Completed	`NCT00164424` - Episodic Acyclovir Therapy for Genital Ulcers	Phase 2/Phase 3
Completed	`NCT00161434` - A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons	Phase 4
Terminated	`NCT04762511` - A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years	Phase 1
Completed	`NCT00699764` - Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease	Phase 3
Recruiting	`NCT04065971` - Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.	Phase 4
Active, not recruiting	`NCT00005663` - A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients	Phase 3